000 03467nam a22003975i 4500
001 85047
003 ES-MaUEC
005 20230207040453.0
007 cr nn 008mamaa
008 151207s2016 gw | s |||| 0|eng d
020 _a9783319247410
040 _aES-MaUEC
050 4 _aRM315
_b2016 EB
082 0 4 _a615.78
245 1 0 _aPharmacovigilance in Psychiatry
_cedited by Edoardo Spina, Gianluca Trifirò
250 _a1st ed.
260 _aCham
_bSpringer International Publishing
_bImprint
_bAdis
_c2016
300 _a1 recurso en línea (XI, 319 páginas)
_b12 ilustraciones en color
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
505 0 _a1. Introduction: History of pharmacovigilance in psychiatry -- 2. Adverse drug reactions: definition and pathogenesis -- 3. Methodologies for pharmacovigilance monitoring of psychotropic drugs -- 4. The role of prescription event monitoring�in pharmacovigilance of psychotropic drugs -- 5. The role of healthcare databases�in pharmacovigilance of psychotropic drugs -- 6. Monitoring of plasma concentrations of psychotropic drugs in pharmacovigilance -- 7. The role of pharmacogenetics in pharmacovigilance of psychotropic drugs -- 8. Safety and tolerability of antidepressants -- 9. Safety and tolerability of antipsychotics -- 10. Safety and tolerability of anxiolytics/sedative hypnotics -- 11. Safety and tolerability of mood stabilizers -- 12. Safety and tolerability of medications for ADHD -- 13. Safety of psychotropic drugs in children and adolescents -- 14. Safety of psychotropic drugs in the elderly(Safety of psychotropic drugs in the elderly -- 15. Safety of psychotropic drugs in pregnancy and breastfeeding.
520 3 _aThe first authoritative textbook specifically addressing issues of the field, this book delivers a focused discussion on several themes in psychiatry while providing a sound background on pharmacovigilance. Internationally-recognised researchers, clinicians and pharmacovigilance experts contributed to this textbook, giving it the benefit of different perspectives and years of experience. Pharmacovigilance in psychiatry provides a thorough introduction to this field but goes on to explore advanced themes such as methodologies and resources used for pharmacovigilance in psychiatry, challenges as well as most recent developments to this field, making it suitable for under-graduates, graduate and post-doctoral students and persons working pharmacovigilance who seek to broaden their knowledge on this subject.
710 2 _aSpringerLink (Online service)
_0Local
_9106996
942 _2lcc
_cLE
650 7 _aMedicina
_0comprobar BNE19900959047
_2embne
_9405021
650 7 _9139882
_aPsicofarmacología
_0comprobar BNE19900978082
_2embne
700 1 _aSpina, Edoardo.
_eeditor literario
_997719
_0Local
700 1 _aTrifirò, Gianluca.
_eeditor literario
_997720
_0Local
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-24741-0
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901 _ai9783319247410
907 _a.b12943253
_b10-10-17
_c21-11-16
988 _aSpringer_Medicine_2016
998 _am
_a_alco
_a_vill
_b - -
_cm
_dz
_e-
_feng
_ggw
_h0
945 _aRM315 .P437 2016 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11587490
_z06-04-17
999 _c85047
_d85047
_x1